Robert Lechleider

Insider Reports History

Entity
Individual
Location
C/O Immunome, Inc., 665 Stockton Drive, Suite 300, PA
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Lechleider:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immunome Inc. Chief Medical Officer Common Stock 15.8K $150K $9.48 Nov 21, 2024 Direct
Immunome Inc. Chief Medical Officer Stock option (right to buy) 200K Aug 9, 2024 Direct

Insider Reports Filed by Robert Lechleider

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMNM Immunome Inc. Nov 21, 2024 1 $150K 4 Nov 25, 2024 Chief Medical Officer
IMNM Immunome Inc. Aug 9, 2024 1 $0 4 Aug 13, 2024 Chief Medical Officer
IMNM Immunome Inc. Oct 27, 2023 1 $0 4 Oct 31, 2023 Chief Medical Officer
IMNM Immunome Inc. Oct 16, 2023 0 $0 3 Oct 20, 2023 Chief Medical Officer